717-1174

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
717 (USA) · Dr. Reyes
consented 2013-01-22

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild INSOMNIA — outcome: RECOVERED/RESOLVED; onset 2013-04-17 (study day 86.0); relationship: POSSIBLE

mild assessed

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-03 (study day 13.0); relationship: PROBABLE

moderate assessed

Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-02-03 (study day 13.0); relationship: PROBABLE

severe assessed

Severe RASH — outcome: RECOVERED/RESOLVED; onset 2013-04-25 (study day 94.0); relationship: REMOTE

mild assessed

Mild SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-26 (study day 5.0); relationship: PROBABLE

moderate assessed

Moderate SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-01-26 (study day 5.0); relationship: PROBABLE

Data queries

No data queries.